Novel composite and humanized anti-TAG-72 monoclonal antibodies, antibody fragments, and derivatives thereof using human subgroup IV kappa light chain framework regions.

Roman zusammengesetzt und gevermenschlichte monoclonal Antikörper anti-TAG-72, Antikörperfragmente und Ableitungen, die davon menschliches Untergruppe IV kappa helle Kettenrahmenregionen verwenden.

 
Web www.patentalert.com

< N-ureidoalkyl-piperidines as modulators of chemokine receptor activity

< Percyquinnin, a process for its production and its use as a pharmaceutical

> Pharmacokinetic-based drug design tool and method

> Biopolymer marker indicative of disease state having molecular weight of 2937 daltons

~ 00079